imidaprilat has been researched along with fumarates in 1 studies
Studies (imidaprilat) | Trials (imidaprilat) | Recent Studies (post-2010) (imidaprilat) | Studies (fumarates) | Trials (fumarates) | Recent Studies (post-2010) (fumarates) |
---|---|---|---|---|---|
30 | 5 | 2 | 4,655 | 342 | 1,823 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ichihara, A; Itoh, H; Kinouchi, K; Kurauchi-Mito, A; Murohashi-Bokuda, K; Narita, T; Nishiyama, A; Sakoda, M; Saleem, MA; Suzuki, F | 1 |
1 other study(ies) available for imidaprilat and fumarates
Article | Year |
---|---|
Aliskiren inhibits intracellular angiotensin II levels without affecting (pro)renin receptor signals in human podocytes.
Topics: Amides; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Biphenyl Compounds; Cells, Cultured; Extracellular Signal-Regulated MAP Kinases; Fumarates; Humans; Imidazolidines; Phosphorylation; Podocytes; Prorenin Receptor; Receptors, Cell Surface; Renin; RNA, Messenger; RNA, Small Interfering; Signal Transduction; Tetrazoles | 2010 |